ATE299934T1 - Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung - Google Patents

Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung

Info

Publication number: ATE299934T1
Authority: AT; Austria
Prior art keywords: leu; pharmaceutical use; terminal sequence; human scf; ser leu
Prior art date: 1994-11-04

Application number

AT95935513T

Other languages

English (en)

Inventor

Andrew Mark Sharkey

Stephen Kevin Smith

Kimberley Anne Dellow

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-04

Filing date

1995-10-31

Publication date

2005-08-15

1994-11-04 Priority claimed from GB9422293A external-priority patent/GB9422293D0/en

1995-04-28 Priority claimed from GBGB9508618.7A external-priority patent/GB9508618D0/en

1995-10-31 Application filed by Applied Research Systems filed Critical Applied Research Systems

2005-08-15 Application granted granted Critical

2005-08-15 Publication of ATE299934T1 publication Critical patent/ATE299934T1/de

Links

210000004899 c-terminal region Anatomy 0.000 abstract 2
GSHKMNKPMLXSQW-KBIXCLLPSA-N Ala-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C)N GSHKMNKPMLXSQW-KBIXCLLPSA-N 0.000 abstract 1
YVYVMJNUENBOOL-KBIXCLLPSA-N Glu-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N YVYVMJNUENBOOL-KBIXCLLPSA-N 0.000 abstract 1
LWYUQLZOIORFFJ-XKBZYTNZSA-N Glu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O LWYUQLZOIORFFJ-XKBZYTNZSA-N 0.000 abstract 1
SOYCWSKCUVDLMC-AVGNSLFASA-N His-Pro-Arg Chemical compound N[C@@H](Cc1cnc[nH]1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)O SOYCWSKCUVDLMC-AVGNSLFASA-N 0.000 abstract 1
NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 abstract 1
SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 abstract 1
DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 abstract 1
108010003201 RGH 0205 Proteins 0.000 abstract 1
VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 abstract 1
KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 abstract 1
DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 abstract 1
210000002459 blastocyst Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
108010005652 splenotritin Proteins 0.000 abstract 1
108010051110 tyrosyl-lysine Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Reproductive Health (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
Gynecology & Obstetrics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Cell Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Developmental Biology & Embryology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT95935513T 1994-11-04 1995-10-31 Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung ATE299934T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9422293A GB9422293D0 (en)	1994-11-04	1994-11-04	Therapeutic protein
GBGB9508618.7A GB9508618D0 (en)	1995-04-28	1995-04-28	Therapeutic protein
PCT/GB1995/002547 WO1996014410A1 (en)	1994-11-04	1995-10-31	Human scf, a splice variant thereof, its pharmaceutical use

Publications (1)

Publication Number	Publication Date
ATE299934T1 true ATE299934T1 (de)	2005-08-15

Family

ID=26305929

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95935513T ATE299934T1 (de)	1994-11-04	1995-10-31	Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung

Country Status (13)

Country	Link
US (1)	US6177556B1 (de)
EP (1)	EP0789761B1 (de)
JP (1)	JP3961565B2 (de)
AT (1)	ATE299934T1 (de)
AU (1)	AU708755B2 (de)
CA (1)	CA2203372C (de)
DE (1)	DE69534324T2 (de)
DK (1)	DK0789761T3 (de)
ES (1)	ES2242192T3 (de)
IL (1)	IL115825A (de)
PT (1)	PT789761E (de)
SI (1)	SI0789761T1 (de)
WO (1)	WO1996014410A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6967092B1 (en)	1996-10-25	2005-11-22	Mc Kearn John P	Multi-functional chimeric hematopoietic receptor agonists
US5969105A (en) *	1996-10-25	1999-10-19	Feng; Yiqing	Stem cell factor receptor agonists
WO1999009141A1 (en) *	1997-08-14	1999-02-25	Biotransplant, Inc.	Porcine totipotent cells and method for long-term culture
US6703209B1 (en)	1998-08-13	2004-03-09	Biotransplant, Inc.	Porcine totipotent cells and method for long-term culture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0423980T3 (da)	1989-10-16	2000-10-09	Amgen Inc	Stamcellefaktor
US5885962A (en) *	1996-04-05	1999-03-23	Amgen Inc.	Stem cell factor analog compositions and method

1995
- 1995-10-31 DK DK95935513T patent/DK0789761T3/da active
- 1995-10-31 AU AU37508/95A patent/AU708755B2/en not_active Expired
- 1995-10-31 US US08/836,252 patent/US6177556B1/en not_active Expired - Lifetime
- 1995-10-31 WO PCT/GB1995/002547 patent/WO1996014410A1/en not_active Ceased
- 1995-10-31 CA CA002203372A patent/CA2203372C/en not_active Expired - Lifetime
- 1995-10-31 SI SI9530720T patent/SI0789761T1/xx unknown
- 1995-10-31 ES ES95935513T patent/ES2242192T3/es not_active Expired - Lifetime
- 1995-10-31 EP EP95935513A patent/EP0789761B1/de not_active Expired - Lifetime
- 1995-10-31 IL IL115825A patent/IL115825A/en not_active IP Right Cessation
- 1995-10-31 DE DE69534324T patent/DE69534324T2/de not_active Expired - Lifetime
- 1995-10-31 PT PT95935513T patent/PT789761E/pt unknown
- 1995-10-31 AT AT95935513T patent/ATE299934T1/de active
- 1995-10-31 JP JP51512196A patent/JP3961565B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI0789761T1 (en)	2005-10-31
CA2203372C (en)	2008-03-11
IL115825A (en)	2006-07-05
AU708755B2 (en)	1999-08-12
DE69534324D1 (de)	2005-08-25
US6177556B1 (en)	2001-01-23
EP0789761A1 (de)	1997-08-20
WO1996014410A1 (en)	1996-05-17
DK0789761T3 (da)	2005-11-28
AU3750895A (en)	1996-05-31
IL115825A0 (en)	1996-01-19
ES2242192T3 (es)	2005-11-01
PT789761E (pt)	2005-09-30
MX9703256A (es)	1998-07-31
JPH10508480A (ja)	1998-08-25
JP3961565B2 (ja)	2007-08-22
EP0789761B1 (de)	2005-07-20
DE69534324T2 (de)	2006-01-05
CA2203372A1 (en)	1996-05-17

Legal Events

Date

Code

Title

Description

2006-02-15

UEP

Publication of translation of european patent specification

Ref document number: 0789761

Country of ref document: EP

2011-04-15

EEFA

Change of the company name

Publication	Publication Date	Title
YU5396A (sh)	1998-08-14	Novi biološki aktivni proteini, njihove farmaceutske formulacije i postupak za njihovo dobijanje
DE59007517D1 (de)	1994-11-24	Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
EP0751992A4 (de)	1997-12-17	Vaskularer endothelialer wachstumsfaktor 2
DK117491A (da)	1991-08-15	Vaccine imod meningococcussygdomme, deri indgaaende komponenter, disses anvendelse og rekombinanter, som eksprimerer dem
ES2144179T3 (es)	2000-06-01	Inhibidores de adhesion ciclicos.
DK1368060T3 (da)	2010-08-30	HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
NZ512083A (en)	2003-02-28	Methods of increasing lean tissue mass using OB protein compositions
BR9406720A (pt)	1996-02-06	Utilização de um adenovírus recombinante de origem animal adenovírus recombinante de origem animal e composição farmacêutica compreendendo um ou vários adenovírus
PT749317E (pt)	2002-11-29	Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
KR900013979A (ko)	1990-10-22	사람 유두종비루스형 16의 e7 단백질상의 면역원성 영역
DE69434777D1 (de)	2006-08-10	Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
EP0810285A3 (de)	1998-07-08	Mutanten von menschlichen Interleukin-3
GR880100775A (el)	1994-03-31	Παράγοντας ενεργοποιήσεως ουδετεροφίλων.
ATE299934T1 (de)	2005-08-15	Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung
NO975565L (no)	1998-01-19	Benstimulerende faktor
NZ334714A (en)	2000-08-25	Liver proteins as agents against autoimmune diseases
KR100488038B1 (ko)	2005-05-09	기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
WO1997012036A3 (en)	1997-06-05	Bone stimulating factor
WO2001051512A3 (en)	2002-03-14	Human and parasite orphan receptor proteins
BR0007816A (pt)	2002-12-31	Fator de estimulação óssea
DE69712182D1 (de)	2002-05-29	Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
MX9205978A (es)	1993-04-01	Nuevas proteinas inhibidoras de trombina de garrapatas.
ATE223227T1 (de)	2002-09-15	Verwendung von lbp zur sepsistherapie
TH34900A (th)	1999-09-14	โปรตีนยับยั้งความอ้วน
ECSP972344A (es)	1998-12-22	Proteinas antiobesidad